Increased serum midkine concentration as a possible tumor marker in patients with superficial esophageal cancer

Oncology Reports

Volumn 10, Issue 2, 2003, Pages 411-414

  Shimada, Hideaki ^a   Nabeya, Yoshihiro ^a   Okazumi, Shin Ichi ^a   Matsubara, Hisahiro ^a   Kadomatsu, Kenji ^b   Muramatsu, Takashi ^b   Ikematsu, Shinya ^c   Sakuma, Sadatoshi ^d   Ochiai, Takenori ^a  

^a CHIBA UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c MEIJI DAIRIES CORPORATION   (Japan)

^d Cell Signals Inc   (Japan)

Author keywords

Esophageal cancer; Midkine; Serum tumor marker; Superficial cancer

Indexed keywords

ANGIOGENIC FACTOR; ANTIGEN CYFRA21.1; CARCINOEMBRYONIC ANTIGEN; CARRIER PROTEIN; CYTOKINE; KERATIN; MIDKINE; SERINE PROTEINASE INHIBITOR; SQUAMOUS CELL CARCINOMA RELATED ANTIGEN; SQUAMOUS CELL CARCINOMA-RELATED ANTIGEN; TUMOR ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD; CANCER INVASION; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGUS TUMOR; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE;

ADULT; AGED; ANGIOGENESIS INDUCING AGENTS; ANTIGENS, NEOPLASM; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, SQUAMOUS CELL; CARRIER PROTEINS; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; KERATINS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; SERPINS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0037810724     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.10.2.411     Document Type: Article

References (26)

1. Isono K and Ochiai T: Recent advances of treatment of cancer of the esophagus (review). Ann Cancer Res Ther 1: 9-16, 1992.
2. Kato H: Diagnosis and treatment of esophageal neoplasms (review). Jpn J Cancer Res 86: 993-1009, 1995.
3. Daly JM, Karnell LH and Menck HR: National cancer data base report on esophageal carcinoma. Cancer 78: 1820-1828, 1996. (Pubitemid 26330913)
4. Kodama M and Kakegawa K: Treatment of superficial cancer of the esophagus: a summary of responses to a questionnaire on superficial cancer of the esophagus in Japan. Surgery 123: 432-439, 1998. (Pubitemid 28201225)
5. Chen YJ, Lee MD and Chen PH: Diagnosis and treatment of superficial esophageal carcinoma. J Gastroenterol Hepatol 12: 778-784, 1997.
6. Lambert R: Endoscopic detection and treatment of early esophageal cancer: a critical analysis. Endoscopy 27: 12-18, 1995.
7. Yokoyama A, Ohmori T, Makuuchi H, Maruyama K, Okuyama K, Takahashi H, Yokoyama T, Yoshino K, Hayashida M and Ishii H: Successful screening for early esophageal cancer in alcoholics using endoscopy and mucosal iodine staining. Cancer 76: 928-934, 1995.
8. Kadomatsu K, Tomomura M and Muramatsu T: cDNA cloning and sequencing of a new gene intensely expressed in early differentiation stages of embryonal carcinoma cells and in midgestation period of mouse embryogenesis. Biochem Biophys Res Commun 151: 1312-1318, 1988. (Pubitemid 18095263)
9. Michikawa M, Xu RY, Muramatsu H, Muramatsu T and Kim SU: Midkine is a mediator of retinoic acid induced neuronal differentiation of embryonal carcinoma cells. Biochem Biophys Res Commun 192: 1312-1318, 1993. (Pubitemid 23218555)
10. Muramatsu T: Midkine (MK), the product of a retinoic acid responsive gene, and pleiotrophin constitute a new protein family regulating growth and differentiation (Review). Int J Dev Biol 37: 183-188, 1993.
11. Unoki K, Ohba N, Arimura H, Muramatsu H and Muramatsu T: Rescue of photoreceptors from the damaging effects of constant light by Midkine, a retinoic acid-responsive gene product. Invest Ophtalmol Vis Sci 35: 907-915, 1994.
12. Tsutsui J, Kadomatsu K, Matsubara S, Nakagawara A, Hamanoue M, Takao S, Shimazu H, Ohi Y and Muramatsu T: A new family of heparin-binding growth/differentiation factors: increased midkine expression in Wilms' tumor and other human carcinomas. Cancer Res 153: 1281-1285, 1993. (Pubitemid 23097103)
13. Garver RI, Chan CS and Milner PG: Reciprocal expression of pleiotrophin and midkine in normal versus malignant lung tissues. Am J Respir Cell Mol Biol 9: 436-463, 1993.
14. Garver RI, Radford DM, Donis-Keller H, Wick MR and Milner PG: Midkine and pleiotrophin expression in normal and malignant breast tissue. Cancer 74: 1584-1590, 1994. (Pubitemid 24302978)
15. Nakagawara A, Milbrandt J, Muramatsu T, Deuel TF, Zhao H, Cnaan A and Brodeur GM: Differential expression of pleiotrophin and midkine in advanced neuroblastomas. Cancer Res 55: 1792-1797, 1995.
16. Aridome K, Tsutsui J, Takao S, Kadomatsu K, Ozawa M, Aikou T and Muramatsu T: Increased midkine gene expression in human gastrointestinal cancers. Jpn J Cancer Res 86: 655-661, 1995.
17. Miyauchi M, Shimada H, Kadomatsu K, Muramatsu T, Matsubara S, Ikematsu S, Takenaga K, Asano T, Ochiai T, Sakiyama S and Tagawa M: Frequent expression of midkine gene in esophageal cancer suggests a potential usage of its promoter for suicide gene therapy. Jpn J Cancer Res 90: 469-475, 1999. (Pubitemid 29213554)
18. Koide N, Hada H, Shinji T, Ujike K, Hirasaki S, Yumoto Y, Hanafusa T, Kadomatsu K, Muramatsu H, Muramatsu T and Tsuji T: Expression of the midkine gene in human hepatocellular carcinomas. Hepatogastroenterology 46: 3189-3196, 1999.
19. Ye C, Qi M, Fan QW, Ito K, Akiyama S, Kasai Y, Matsuyama M, Muramatsu T and Kadomatsu K: Expression of midkine in the early stage of carcinogenesis in human colorectal cancer. Br J Cancer 79: 179-184, 1999. (Pubitemid 28566945)
20. Muramatsu H, Song XJ, Koide N, Hada H, Tsuji T, Kadomatsu K, Inui T, Kimura T, Sakakibara S and Muramatsu T: Enzyme-linked immunoassay for midkine, and its application to evaluation of midkine levels in developing mouse brain and sera from patients with hepatocellular carcinomas. J Biochem 119: 1171-1175, 1996. (Pubitemid 26202633)
21. Song XJ, Muramatsu H, Aridome K, Aikou T, Koide N, Tsuji T and Muramatsu T: The serum level of midkine, a heparin-binding growth factor, as a tumor marker. Biomed Res 18: 375-381, 1997. (Pubitemid 27523630)
22. Ikematsu S, Yano A, Aridome K, Kikuchi M, Kumai H, Nagano H, Okamoto K, Oda M, Sakuma S, Aikou T, Muramatsu H, Kadomatsu K and Muramatsu T: Serum midkine levels are increased in patients with various types of carcinomas. Br J Cancer 83: 701-706, 2000.
23. The Japanese Society of Esophageal Diseaes: In: Comprehensive Registry of Esophageal cancer in Japan (1995, 1996, 1997). 2nd edition. 87, 2001.
24. Sobin LH and Wittekind Ch (eds): UICC TNM Classification of malignant tumors. 5th edition. John Wiley & Sons, Inc., New York, 1997.
25. Schlemper RJ, Dawsey SM, Itabashi M, Iwashita A, Kato Y, Koike M, Lewin KJ, Riddell RH, Shimoda T, Sipponen P, Stolte M and Watanabe H: Differences in diagnostic criteria for esophageal squamous cell carcinoma between Japanese and Western pathologists. Cancer 89: 996-1006, 2000. (Pubitemid 30127658)
26. Kadomatsu K, Hagihara M, Akhter S, Fan QW, Muramatsu H and Muramatsu T: Midkine induces the transformation of NIH3T3 cells. Br J Cancer 75: 354-359, 1997. (Pubitemid 27051049)